UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
20.11
+0.91 (4.74%)
At close: Aug 13, 2025, 4:00 PM
19.95
-0.16 (-0.80%)
Pre-market: Aug 14, 2025, 8:43 AM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $930.37 million as of August 14, 2025. Its market cap has increased by 57.50% in one year.
Market Cap
930.37M
Enterprise Value
896.25M
1-Year Change
57.50%
Ranking
Category
Stock Price
$20.11
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $930.37M, an increase of 411.47%. That is a compound annual growth rate of 21.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 888.30M | 97.66% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |